大会联合主席、创新中心特聘研究员兼肿瘤研究所所长李国民代表组委会，向拨冗参会的各界人士致以诚挚欢迎。他感谢了演讲嘉宾在科研与临床的忙碌中分享前沿成果，赞扬了创新中心行政团队筹备的精心高效以及志愿者在后勤会务方面的无私奉献。

在肿瘤研究蓬勃发展但仍面临诸多挑战的当下，本次论坛旨在集结全球范围内出类拔萃的肿瘤生物学家与医师科学家，在这一平台上，全方位、深层次地探讨肿瘤学领域的最新突破性进展、前沿探索方向。

李国民强调，创新中心作为新型研发机构，所举办的CIMR国际肿瘤论坛遵循国际化会议惯例，摒弃形式主义。论坛不设会前会后的领导致辞环节，参会者自由就座，发言顺序亦不再依据身份高低排列，而是围绕讨论主题展开。论坛始终秉持开放包容、积极互动的交流理念，热烈欢迎并积极鼓励不同专业背景、不同资历的参会者踊跃投身于讨论环节。通过多元视角的交融，充分激发思维活力，让参会者畅所欲言，分享独到见解与宝贵经验，为肿瘤学领域的知识边界拓展、技术革新注入源源不断的动力，推动整个学科向着攻克肿瘤难题、造福人类健康的目标大步迈进。

Speaker风采

黄亚平主持 Session I: Cancer immune signaling

董晨：Mechanisms underlying responsiveness and resistance to cancer immunotherapy

傅阳心：New strategies for targeted cancer immunotherapy

刘万里：The past, present and future of a germline variant in hIgG1 coding gene IGHG1

孙少聪：Regulation CD8 T cell dynamics and function in cancer

主鸿鹄主持 Session II: Cancer metabolism

程涛：Disrupted niche function for normal hematopoiesis in AML is restorable with IL-1R antagonist therapy

吕志民：Metabolic reprogramming and immune evasion in cancer

梁德光：Exploiting phospholipid remodeling pathways for cancer treatment

吕军华：Rewired metabolism as a targetable liability of IDH-mutant leukemia

何文辉主持 Session III: New technologies and approaches in cancer research

张康：Big data and artificial intelligence: catalysts for innovation in medicine and healthcare

刘志博：Radiopharmaceuticals and radiotherapy-activated prodrugs

沈志荣：Innovative oncology therapies based on diverse modalities and translational disease insights

邓子厚：Exploration of macrophages as therapeutic targets in cancer treatment

张昱主持 Session IV: Genome maintenance systems in cancer

卢欣：Cancer-causing pathogens, cell plasticity and upper GI cancer

胡家志：The formation of DNA replication-coupled chromatin structures

尤忠胜：A tango between STING and TRPV2 on the ER: genome protection and immune regulation

精彩瞬间